Cargando…

Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs

Medulloblastoma (MB) is the most common malignant brain tumor in children. There remains an unmet need for diagnostics to sensitively detect the disease, particularly recurrences. Cerebrospinal fluid (CSF) provides a window into the central nervous system, and liquid biopsy of CSF could provide a re...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Bongyong, Mohamad, Iqbal, Pokhrel, Rudramani, Murad, Rabi, Yuan, Menglang, Stapleton, Stacie, Bettegowda, Chetan, Jallo, George, Eberhart, Charles G., Garrett, Timothy, Perera, Ranjan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867780/
https://www.ncbi.nlm.nih.gov/pubmed/35209946
http://dx.doi.org/10.1186/s40478-022-01326-7
_version_ 1784656123909898240
author Lee, Bongyong
Mohamad, Iqbal
Pokhrel, Rudramani
Murad, Rabi
Yuan, Menglang
Stapleton, Stacie
Bettegowda, Chetan
Jallo, George
Eberhart, Charles G.
Garrett, Timothy
Perera, Ranjan J.
author_facet Lee, Bongyong
Mohamad, Iqbal
Pokhrel, Rudramani
Murad, Rabi
Yuan, Menglang
Stapleton, Stacie
Bettegowda, Chetan
Jallo, George
Eberhart, Charles G.
Garrett, Timothy
Perera, Ranjan J.
author_sort Lee, Bongyong
collection PubMed
description Medulloblastoma (MB) is the most common malignant brain tumor in children. There remains an unmet need for diagnostics to sensitively detect the disease, particularly recurrences. Cerebrospinal fluid (CSF) provides a window into the central nervous system, and liquid biopsy of CSF could provide a relatively non-invasive means for disease diagnosis. There has yet to be an integrated analysis of the transcriptomic, metabolomic, and lipidomic changes occurring in the CSF of children with MB. CSF samples from patients with (n = 40) or without (n = 11; no cancer) MB were subjected to RNA-sequencing and high-resolution mass spectrometry to identify RNA, metabolite, and lipid profiles. Differentially expressed transcripts, metabolites, and lipids were identified and their biological significance assessed by pathway analysis. The DIABLO multivariate analysis package (R package mixOmics) was used to integrate the molecular changes characterizing the CSF of MB patients. Differentially expressed transcripts, metabolites, and lipids in CSF were discriminatory for the presence of MB but not the exact molecular subtype. One hundred and ten genes and ten circular RNAs were differentially expressed in MB CSF compared with normal, representing TGF-β signaling, TNF-α signaling via NF-kB, and adipogenesis pathways. Tricarboxylic acid cycle and other metabolites (malate, fumarate, succinate, α-ketoglutarate, hydroxypyruvate, N-acetyl-aspartate) and total triacylglycerols were significantly upregulated in MB CSF compared with normal CSF. Although separating MBs into subgroups using transcriptomic, metabolomic, and lipid signatures in CSF was challenging, we were able to identify a group of omics signatures that could separate cancer from normal CSF. Metabolic and lipidomic profiles both contained indicators of tumor hypoxia. Our approach provides several candidate signatures that deserve further validation, including the novel circular RNA circ_463, and insights into the impact of MB on the CSF microenvironment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-022-01326-7.
format Online
Article
Text
id pubmed-8867780
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88677802022-02-25 Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs Lee, Bongyong Mohamad, Iqbal Pokhrel, Rudramani Murad, Rabi Yuan, Menglang Stapleton, Stacie Bettegowda, Chetan Jallo, George Eberhart, Charles G. Garrett, Timothy Perera, Ranjan J. Acta Neuropathol Commun Research Medulloblastoma (MB) is the most common malignant brain tumor in children. There remains an unmet need for diagnostics to sensitively detect the disease, particularly recurrences. Cerebrospinal fluid (CSF) provides a window into the central nervous system, and liquid biopsy of CSF could provide a relatively non-invasive means for disease diagnosis. There has yet to be an integrated analysis of the transcriptomic, metabolomic, and lipidomic changes occurring in the CSF of children with MB. CSF samples from patients with (n = 40) or without (n = 11; no cancer) MB were subjected to RNA-sequencing and high-resolution mass spectrometry to identify RNA, metabolite, and lipid profiles. Differentially expressed transcripts, metabolites, and lipids were identified and their biological significance assessed by pathway analysis. The DIABLO multivariate analysis package (R package mixOmics) was used to integrate the molecular changes characterizing the CSF of MB patients. Differentially expressed transcripts, metabolites, and lipids in CSF were discriminatory for the presence of MB but not the exact molecular subtype. One hundred and ten genes and ten circular RNAs were differentially expressed in MB CSF compared with normal, representing TGF-β signaling, TNF-α signaling via NF-kB, and adipogenesis pathways. Tricarboxylic acid cycle and other metabolites (malate, fumarate, succinate, α-ketoglutarate, hydroxypyruvate, N-acetyl-aspartate) and total triacylglycerols were significantly upregulated in MB CSF compared with normal CSF. Although separating MBs into subgroups using transcriptomic, metabolomic, and lipid signatures in CSF was challenging, we were able to identify a group of omics signatures that could separate cancer from normal CSF. Metabolic and lipidomic profiles both contained indicators of tumor hypoxia. Our approach provides several candidate signatures that deserve further validation, including the novel circular RNA circ_463, and insights into the impact of MB on the CSF microenvironment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-022-01326-7. BioMed Central 2022-02-24 /pmc/articles/PMC8867780/ /pubmed/35209946 http://dx.doi.org/10.1186/s40478-022-01326-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lee, Bongyong
Mohamad, Iqbal
Pokhrel, Rudramani
Murad, Rabi
Yuan, Menglang
Stapleton, Stacie
Bettegowda, Chetan
Jallo, George
Eberhart, Charles G.
Garrett, Timothy
Perera, Ranjan J.
Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs
title Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs
title_full Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs
title_fullStr Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs
title_full_unstemmed Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs
title_short Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs
title_sort medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific rnas
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867780/
https://www.ncbi.nlm.nih.gov/pubmed/35209946
http://dx.doi.org/10.1186/s40478-022-01326-7
work_keys_str_mv AT leebongyong medulloblastomacerebrospinalfluidrevealsmetabolitesandlipidsindicativeofhypoxiaandcancerspecificrnas
AT mohamadiqbal medulloblastomacerebrospinalfluidrevealsmetabolitesandlipidsindicativeofhypoxiaandcancerspecificrnas
AT pokhrelrudramani medulloblastomacerebrospinalfluidrevealsmetabolitesandlipidsindicativeofhypoxiaandcancerspecificrnas
AT muradrabi medulloblastomacerebrospinalfluidrevealsmetabolitesandlipidsindicativeofhypoxiaandcancerspecificrnas
AT yuanmenglang medulloblastomacerebrospinalfluidrevealsmetabolitesandlipidsindicativeofhypoxiaandcancerspecificrnas
AT stapletonstacie medulloblastomacerebrospinalfluidrevealsmetabolitesandlipidsindicativeofhypoxiaandcancerspecificrnas
AT bettegowdachetan medulloblastomacerebrospinalfluidrevealsmetabolitesandlipidsindicativeofhypoxiaandcancerspecificrnas
AT jallogeorge medulloblastomacerebrospinalfluidrevealsmetabolitesandlipidsindicativeofhypoxiaandcancerspecificrnas
AT eberhartcharlesg medulloblastomacerebrospinalfluidrevealsmetabolitesandlipidsindicativeofhypoxiaandcancerspecificrnas
AT garretttimothy medulloblastomacerebrospinalfluidrevealsmetabolitesandlipidsindicativeofhypoxiaandcancerspecificrnas
AT pereraranjanj medulloblastomacerebrospinalfluidrevealsmetabolitesandlipidsindicativeofhypoxiaandcancerspecificrnas